| Company Name: | Qiagen N.V. | | Ticker Symbol: | QGEN | | | WWW Address: | www.qiagen.com | | CEO: | Peer M. Schatz | | No. of Employees: | 3,041 | | Common Issue Type: | CS | | Business Description: | The Company develops and markets a range of proprietary products for the academic and industrial research markets as well as for the applied testing and molecular diagnostics markets.
|
| | | Industry Information: | DRUGS - Biotechnology [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 21.95 |  0.59 | 21.78 | 22.99 | 21.64 | 22.04 | 21.60 | 1338390 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 5,072.6 | 231.1 | 0.77 | 0.44 | 0.00 | 37.8 | 0.0 | 23.58 - 14.32 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 21.95 | $ | | PE Ratio - LTM | 37.8 | |
| Market Capitalisation | 5,073.3 | mil |
| Latest Shares Outstanding | 231.1 | mil |
| Earnings pS (EPS) | 0.44 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 293,645 | $ |
| Effective Tax Rate | 25.0 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | 0.0 | % |
| Foreign Sales | 893 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 38.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 11.00 | % |
| Gross Profit Margin | 77.0 | % |
| EBITDA Margin | 28.0 | % |
| Pre-Tax Profit Margin | 16.6 | % |
| Assets Turnover | 0.3 | % |
| Return on Assets (ROA) | 3.1 | % |
| Return on Equity (ROE) | 5.3 | % |
| Return on Capital Invested (ROCI) | 3.8 | % |
| Current Ratio | 3.6 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 6.2 | |
| Total Debt/Equity (Gearing Ratio) | 0.43 | |
| LT Debt/Total Capital | 29.0 | % |
| Working Capital pS | 4.31 | $ |
| Cash pS | 3.73 | $ |
| Book-Value pS | 9.64 | $ |
| Tangible Book-Value pS | 1.13 | $ |
| Cash Flow pS | 1.00 | $ |
| Free Cash Flow pS | 0.03 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.28 | |
| Price/Tangible Book Ratio | 19.45 | |
| Price/Cash Flow | 21.9 | |
| Price/Free Cash Flow | 667.5 | |
| P/E as % of Industry Group | 167.0 | % |
| P/E as % of Sector Segment | 27.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.0 | 100 | 10,302 | 37,918 |
| 4 Weeks | 23.58 | 20.56 | 20.83 | 5.4 | 98 | 10,644 | 191,586 |
| 13 Weeks | 23.58 | 20.05 | 20.52 | 7.0 | 99 | 11,766 | 729,481 |
| 26 Weeks | 23.58 | 17.20 | 17.60 | 24.7 | 103 | 9,782 | 1,232,536 |
| 52 Weeks | 23.58 | 14.32 | 16.13 | 36.1 | 110 | 10,265 | 2,566,244 |
| YTD | 23.58 | 14.32 | - | 25.0 | 102 | 10,612 | 2,419,496 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 21.73 | 22.08 | 21.55 | 19.66 | 18.68 | 0.77 | 0.79 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 21.91 | 92.3 | 27.08 |
| Income | 7.04 | 27.2 | 7.34 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 104.30 | NA | 53.48 |
| R&D | 27.18 | NA | 36.34 |
| Normalized Inc. | 7.05 | NA | -2.49 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 9.9 | 12.5 | 37.4 |
| Earnings % | 45.0 | 81.3 | 77.6 |
| EPS % | 45.2 | 80.0 | 57.1 |
| EPS $ | 0.14 | 0.08 | 0.16 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 15.29 |
| Current Ratio | 2.7 |
| Quick Ratio (Acid Test) | 2.0 |
| Liquidity Ratio (Cash) | 1.27 |
| Receivables Turnover | 5.4 |
| Average Collection Period | 67 |
| Working Capital/Equity | 30.3 |
| Working Capital pS | 2.23 |
| Cash-Flow pS | 0.98 |
| Free Cash-Flow pS | -0.18 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.83 |
| Financial Leverage Ratio (Assets/Equity) | 2.0 |
| Debt Ratio | 49.6 |
| Total Debt/Equity (Gearing Ratio) | 0.67 |
| LT Debt/Equity | 0.65 |
| LT Debt/Capital Invested | 48.6 |
| LT Debt/Total Liabilities | 66.3 |
| Interest Cover | 4.2 |
| Interest/Capital Invested | 1.43 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 5.03 |
| Tobin's Q Ratio | 1.76 |
| Current P/E Ratio - LTM | 37.80 |
| Enterprise Value (EV)/EBITDA | 23.14 |
| Enterprise Value (EV)/Free Cash Flow | -158.90 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 19.45 |
| Price/Book Ratio - LTM | 2.28 |
| Price/Cash Flow Ratio | 21.9 |
| Price/Free Cash Flow Ratio - LTM | 667.5 |
| Price/Sales Ratio | 5.30 |
| P/E Ratio (1 month ago) - LTM | 37.2 |
| P/E Ratio (26 weeks ago) - LTM | 38.3 |
| P/E Ratio (52 weeks ago) - LTM | 42.4 |
| 5-Y High P/E Ratio | 85.1 |
| 5-Y Low P/E Ratio | 25.1 |
| 5-Y Average P/E Ratio | 42.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 90 |
| P/E as % of Industry Group | 167.0 |
| P/E as % of Sector Segment | 27.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 47.2 |
| PER SHARE FIGURES |
| LT Debt pS | 4.80 |
| Current Liabilities pS | 1.33 |
| Tangible Book Value pS - LTM | 1.13 |
| Book Value pS - LTM | 9.64 |
| Capital Invested pS | 10.40 |
| Cash pS - LTM | 3.73 |
| Cash Flow pS - LTM | 1.00 |
| Free Cash Flow pS - LTM | 0.03 |
| Earnings pS (EPS) | 0.44 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -3.97 |
| Free Cash Flow Margin 5YEAR AVG | -25.77 |
| Net Profit Margin | 10.0 |
| Net Profit Margin - 5YEAR AVRG. | 11.5 |
| Equity Productivity | 0.61 |
| Return on Equity (ROE) | 6.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 7.5 |
| Capital Invested Productivity | 0.37 |
| Return on Capital Invested (ROCI) | 3.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 4.5 |
| Assets Productivity | 0.30 |
| Return on Assets (ROA) | 3.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 3.8 |
| Gross Profit Margin | 77.0 |
| Gross Profit Margin - 5YEAR AVRG. | 76.2 |
| EBITDA Margin - LTM | 28.0 |
| EBIT Margin - LTM | 19.8 |
| Pre-Tax Profit Margin | 13.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 16.9 |
| Effective Tax Rate | 25.0 |
| Effective Tax Rate - 5YEAR AVRG. | 32.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 261 |
| Revenue per Employee | 293,645 |
| Net Income per Employee | 29,278 |
| Average Collection Period | 72 |
| Receivables Turnover | 5.4 |
| Day's Inventory Turnover Ratio | 189 |
| Inventory Turnover | 1.9 |
| Inventory/Sales | 12.2 |
| Accounts Payble/Sales | 5.47 |
| Assets/Revenue | 3.33 |
| Net Working Capital Turnover | 2.02 |
| Fixed Assets Turnover | 0.41 |
| Total Assets Turnover | 0.3 |
| Revenue per $ Cash | 2.68 |
| Revenue per $ Plant | 3.08 |
| Revenue per $ Common Equity | 0.61 |
| Revenue per $ Capital Invested | 0.37 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 38.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 36.1 |
| Research & Devlopment (R&D) as % of Revenue | 10.9 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 10.9 |
|
|  
|
| |
 |  |